KARBE FRANK
Insider CIK 1276700 · ADRO Director · ABUS Director · CDTX Chief Financial Officer · MYOV Principal Fin'l & Accounting · PHAT Director · BTTX See Remarks, Director · EXEL EVP and CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PHAT Phathom Pharmaceuticals, I | A Award | 2026-05-19 | 2026-05-21 | 24,122 | — | $0 | 91,622 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 115,000 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer | 2026-01-07 | 2026-01-07 | 43,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer | 2026-01-07 | 2026-01-07 | 7,526 | $221.50 | $1.67M | 43,125 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | F Tax w/h | 2025-12-10 | 2025-12-12 | 7,290 | $219.60 | $1.60M | 50,562 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2025-06-03 | 2025-06-05 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2025-06-03 | 2025-06-05 | 10,500 | — | $0 | 67,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2025-02-24 | 2025-02-26 | 115,000 | — | $0 | 115,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award | 2025-02-24 | 2025-02-26 | 57,500 | — | $0 | 57,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | P Buy | 2024-12-13 | 2024-12-16 | 12,500 | $7.93 | $99.1K | 57,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2024-05-29 | 2024-05-31 | 25,000 | $10.16 | $254.0K | 44,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2024-05-23 | 2024-05-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2024-05-23 | 2024-05-24 | 10,500 | — | $0 | 19,500 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award | 2023-12-18 | 2023-12-20 | 62,500 | — | $0 | 526,516 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2023-07-27 | 2023-07-31 | 137,005 | $0.73 | $100.0K | 429,429 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2023-05-25 | 2023-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award | 2023-05-25 | 2023-05-30 | 9,000 | — | $0 | 9,000 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2023-04-10 | 2023-04-12 | 242,424 | $0.83 | $201.2K | 292,424 | SEC↗ |
| BTTX Better Therapeutics, Inc. | P Buy | 2022-09-15 | 2022-09-15 | 50,000 | $2.09 | $104.5K | 50,000 | SEC↗ |
| BTTX Better Therapeutics, Inc. | A Award deriv | 2022-07-05 | 2022-07-07 | 472,200 | — | $0 | 472,200 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2022-05-25 | 2022-05-27 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PHAT Phathom Pharmaceuticals, I | A Award deriv | 2022-04-25 | 2022-04-26 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-07-07 | 2021-07-09 | 3,232 | $21.75 | $70.3K | 212,296 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2021-04-15 | 2021-04-19 | 97,534 | — | $0 | 97,534 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2021-04-15 | 2021-04-19 | 63,138 | — | $0 | 215,528 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-04-06 | 2021-04-08 | 11,080 | $18.63 | $206.4K | 152,390 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2021-02-16 | 2021-02-18 | 750 | — | $0 | 181,744 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-02-16 | 2021-02-18 | 750 | $21.40 | $16.0K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2021-02-16 | 2021-02-18 | 750 | $5.11 | $3.8K | 164,220 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2021-01-28 | 2021-02-01 | 300 | — | $0 | 182,494 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2021-01-28 | 2021-02-01 | 300 | $5.11 | $1.5K | 163,770 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-01-28 | 2021-02-01 | 300 | $24.00 | $7.2K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2021-01-15 | 2021-01-20 | 750 | — | $0 | 182,794 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2021-01-15 | 2021-01-20 | 750 | $21.50 | $16.1K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2021-01-15 | 2021-01-20 | 750 | $5.11 | $3.8K | 164,220 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-12-28 | 2020-12-30 | 11,800 | — | $0 | 183,544 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-12-28 | 2020-12-30 | 11,800 | $5.11 | $60.3K | 175,270 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-12-28 | 2020-12-30 | 11,800 | $30.00 | $354.0K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-12-15 | 2020-12-17 | 1,050 | — | $0 | 195,344 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-12-15 | 2020-12-17 | 670 | $24.45 | $16.4K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-12-15 | 2020-12-17 | 1,050 | $5.11 | $5.4K | 164,520 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-12-15 | 2020-12-17 | 380 | $23.63 | $9.0K | 164,140 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-11-30 | 2020-12-02 | 1,500 | — | $0 | 196,394 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-11-30 | 2020-12-02 | 1,500 | $24.00 | $36.0K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-11-30 | 2020-12-02 | 1,500 | $5.11 | $7.7K | 164,970 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-11-17 | 2020-11-19 | 750 | — | $0 | 197,894 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-11-17 | 2020-11-19 | 750 | $5.11 | $3.8K | 164,220 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-11-17 | 2020-11-19 | 750 | $20.00 | $15.0K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-11-13 | 2020-11-17 | 750 | — | $0 | 198,644 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-11-13 | 2020-11-17 | 750 | $5.11 | $3.8K | 164,220 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-11-13 | 2020-11-17 | 750 | $20.00 | $15.0K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-09-15 | 2020-09-17 | 750 | — | $0 | 199,394 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-09-15 | 2020-09-17 | 750 | $5.11 | $3.8K | 164,220 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-09-15 | 2020-09-17 | 750 | $21.73 | $16.3K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-08-31 | 2020-09-01 | 21,150 | — | $0 | 200,144 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-08-31 | 2020-09-01 | 21,150 | $20.01 | $423.2K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-08-31 | 2020-09-01 | 21,150 | $5.11 | $108.1K | 184,620 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-08-28 | 2020-09-01 | 3,650 | — | $0 | 221,294 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-08-28 | 2020-09-01 | 3,650 | $20.04 | $73.1K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-08-28 | 2020-09-01 | 3,650 | $5.11 | $18.7K | 167,120 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise deriv | 2020-08-19 | 2020-08-21 | 700 | — | $0 | 224,944 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2020-08-19 | 2020-08-21 | 700 | $20.00 | $14.0K | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | M Exercise | 2020-08-19 | 2020-08-21 | 700 | $5.11 | $3.6K | 164,170 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2020-05-05 | 2020-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2020-04-03 | 2020-04-07 | 183,991 | — | $0 | 183,991 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2020-04-03 | 2020-04-07 | 120,146 | — | $0 | 163,470 | SEC↗ |
| MYOV Myovant Sciences Ltd. | S Sale | 2019-12-30 | 2019-12-30 | 19,701 | $15.55 | $306.4K | 43,324 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2019-08-26 | 2019-08-27 | 200,000 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2019-08-26 | 2019-08-27 | 200,000 | — | $0 | 200,000 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2019-08-26 | 2019-08-27 | 114,690 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2019-08-26 | 2019-08-27 | 114,690 | — | $0 | 114,690 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2019-08-26 | 2019-08-27 | 132,270 | — | $0 | 132,270 | SEC↗ |
| MYOV Myovant Sciences Ltd. | D To issuer deriv | 2019-08-26 | 2019-08-27 | 132,270 | — | $0 | 0 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award | 2019-08-26 | 2019-08-27 | 55,025 | — | $0 | 63,025 | SEC↗ |
| MYOV Myovant Sciences Ltd. | P Buy | 2019-06-11 | 2019-06-11 | 8,000 | $9.10 | $72.8K | 8,000 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2019-05-14 | 2019-05-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ADRO ADURO BIOTECH, INC. | A Award deriv | 2019-04-18 | 2019-04-19 | 60,000 | — | $0 | 60,000 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2019-04-05 | 2019-04-09 | 132,270 | — | $0 | 132,270 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2018-04-16 | 2018-04-18 | 114,690 | — | $0 | 114,690 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2017-06-21 | 2017-06-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| MYOV Myovant Sciences Ltd. | A Award deriv | 2017-05-15 | 2017-05-17 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2016-06-03 | 2016-06-07 | 7,500 | — | $0 | 7,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2015-08-12 | 2015-08-14 | 7,500 | — | $0 | 7,500 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2014-02-15 | 2014-02-18 | 1,954 | — | $0 | 0 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2014-02-15 | 2014-02-18 | 1,954 | — | $0 | 94,847 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2014-02-15 | 2014-02-18 | 857 | — | $0 | 93,990 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2013-11-15 | 2013-11-15 | 1,953 | — | $0 | 1,954 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2013-11-15 | 2013-11-15 | 733 | — | $0 | 92,893 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2013-11-15 | 2013-11-15 | 1,953 | — | $0 | 93,626 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2013-09-18 | 2013-09-19 | 180,000 | — | $0 | 180,000 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2013-08-15 | 2013-08-16 | 1,953 | — | $0 | 3,907 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2013-08-15 | 2013-08-16 | 733 | — | $0 | 90,515 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2013-08-15 | 2013-08-16 | 1,953 | — | $0 | 91,248 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2013-05-15 | 2013-05-17 | 1,953 | — | $0 | 5,860 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2013-05-15 | 2013-05-17 | 735 | — | $0 | 89,295 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2013-05-15 | 2013-05-17 | 1,953 | — | $0 | 90,030 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2013-02-15 | 2013-02-15 | 1,953 | — | $0 | 7,813 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2013-02-15 | 2013-02-15 | 915 | — | $0 | 81,789 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2013-02-15 | 2013-02-15 | 1,953 | — | $0 | 82,704 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise deriv | 2012-11-15 | 2012-11-16 | 1,953 | — | $0 | 9,766 | SEC↗ |
| EXEL EXELIXIS, INC. | M Exercise | 2012-11-15 | 2012-11-16 | 1,953 | — | $0 | 81,467 | SEC↗ |
| EXEL EXELIXIS, INC. | F Tax w/h | 2012-11-15 | 2012-11-16 | 716 | — | $0 | 80,751 | SEC↗ |
| EXEL EXELIXIS, INC. | A Award deriv | 2012-09-21 | 2012-09-21 | 123,000 | — | $0 | 123,000 | SEC↗ |
| EXEL EXELIXIS INC | M Exercise deriv | 2012-08-15 | 2012-08-17 | 1,953 | — | $0 | 11,719 | SEC↗ |
| EXEL EXELIXIS INC | M Exercise | 2012-08-15 | 2012-08-17 | 1,953 | — | $0 | 77,360 | SEC↗ |
| EXEL EXELIXIS INC | F Tax w/h | 2012-08-15 | 2012-08-17 | 716 | — | $0 | 76,644 | SEC↗ |
| EXEL EXELIXIS INC | M Exercise deriv | 2012-05-15 | 2012-05-17 | 1,953 | — | $0 | 13,672 | SEC↗ |
| EXEL EXELIXIS INC | F Tax w/h | 2012-05-15 | 2012-05-17 | 716 | — | $0 | 75,407 | SEC↗ |
| EXEL EXELIXIS INC | M Exercise | 2012-05-15 | 2012-05-17 | 1,953 | — | $0 | 76,123 | SEC↗ |
| EXEL EXELIXIS INC | M Exercise deriv | 2012-02-15 | 2012-02-17 | 1,953 | — | $0 | 15,625 | SEC↗ |
| EXEL EXELIXIS INC | F Tax w/h | 2012-02-15 | 2012-02-17 | 6,099 | — | $0 | 74,170 | SEC↗ |
| EXEL EXELIXIS INC | M Exercise | 2012-02-15 | 2012-02-17 | 1,953 | — | $0 | 80,269 | SEC↗ |